Suppr超能文献

信息警戒:报告官方药品信息来源中的错误。

Infovigilance: reporting errors in official drug information sources.

作者信息

Fusier Isabelle, Tollier Corinne, Husson Marie-Caroline

机构信息

Centre National Hospitalier d'Information sur le Médicament, (CNHIM), Hôpital Bicêtre, 78, rue du Général Leclerc, BP 11, 94272, Le Kremlin Bicêtre Cedex, France.

出版信息

Pharm World Sci. 2005 Jun;27(3):166-9. doi: 10.1007/s11096-004-1733-2.

Abstract

INTRODUCTION

The French drug database Thériaque (http://www.theriaque.org) developed by the (Centre National Hospitalier d'Information sur le Médicament) (CNHIM), is responsible for the dissemination of independent information about all drugs available in France. Each month the CNHIM pharmacists report problems due to inaccuracies in these sources to the French drug agency. In daily practice we devised the term "infovigilance": "Activity of error or inaccuracy notification in information sources which could be responsible for medication errors". The aim of this study was to evaluate the impact of CNHIM infovigilance on the contents of the Summary of Product Characteristics (SPCs).

METHOD

The study was a prospective study from 09/11/2001 to 31/12/2002. The problems related to the quality of information were classified into four types (inaccuracy/confusion, error/lack of information, discordance between SPC sections and discordance between generic SPCs).

MAIN OUTCOME MEASURES

(1) Number of notifications and number of SPCs integrated into the database during the study period. (2) Percentage of notifications for each type: with or without potential patient impact, with or without later correction of the SPC, per section.

RESULTS

2.7% (85/3151) of SPCs integrated into the database were concerned by a notification of a problem. Notifications according to type of problem were inaccuracy/confusion (32%), error/lack of information (13%), discordance between SPC sections (27%) and discordance between generic SPCs (28%). 55% of problems were evaluated as 'likely to have an impact on the patient' and 45% as 'unlikely to have an impact on the patient'. 22 of problems which have been reported to the French drug agency were corrected and new updated SPCs were published with the corrections.

CONCLUSIONS

Our efforts to improve the quality of drug information sources through a continuous "infovigilance" process need to be continued and extended to other information sources.

摘要

引言

由法国国家药品信息中心(CNHIM)开发的法国药品数据库Thériaque(http://www.theriaque.org)负责传播有关法国所有可用药品的独立信息。每月,CNHIM的药剂师会向法国药品管理机构报告这些信息来源中存在的不准确问题。在日常实践中,我们创造了“信息警戒”一词:“在可能导致用药错误的信息来源中进行错误或不准确通知的活动”。本研究的目的是评估CNHIM信息警戒对产品特性摘要(SPC)内容的影响。

方法

该研究是一项从2001年11月9日至2002年12月31日的前瞻性研究。与信息质量相关的问题分为四种类型(不准确/混淆、错误/信息缺失、SPC各部分之间不一致以及通用SPC之间不一致)。

主要观察指标

(1)研究期间纳入数据库的通知数量和SPC数量。(2)每种类型通知的百分比:按是否对患者有潜在影响、SPC是否随后进行了修正、按各部分划分。

结果

纳入数据库的SPC中有2.7%(85/3151)受到问题通知的影响。根据问题类型的通知分别为不准确/混淆(32%)、错误/信息缺失(13%)、SPC各部分之间不一致(27%)以及通用SPC之间不一致(28%)。55%的问题被评估为“可能对患者有影响”,45%为“不太可能对患者有影响”。已报告给法国药品管理机构的问题中有22个得到了纠正,并发布了包含修正内容的新的更新SPC。

结论

我们通过持续的“信息警戒”过程来提高药品信息来源质量的努力需要继续并扩展到其他信息来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验